Icatibant in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Case Report

J Investig Allergol Clin Immunol. 2021 Oct 25;31(5):451-452. doi: 10.18176/jiaci.0659. Epub 2020 Dec 4.
No abstract available

Keywords: COVID-19; Contact system; Icatibant; SARS-CoV-2; Severe acute respiratory syndrome.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Bradykinin / analogs & derivatives*
  • Bradykinin / therapeutic use
  • Bradykinin B2 Receptor Antagonists / therapeutic use*
  • COVID-19 / diagnosis
  • COVID-19 / physiopathology
  • COVID-19 Drug Treatment*
  • Humans
  • Lung / drug effects
  • Lung / physiopathology
  • Male
  • Middle Aged
  • SARS-CoV-2
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Bradykinin B2 Receptor Antagonists
  • icatibant
  • Bradykinin